4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-003347
CFO & Chief Business Officer sold 4,160 shares at an average $1.83 ($7,607)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zuga Matt CFO & Chief Business Officer | 2026-01-21 | Sale | −2,473 | $1.81 | $4,469 | 306,611 | D |
| Zuga Matt CFO & Chief Business Officer | 2026-01-22 | Sale | −1,687 | $1.86 | $3,138 | 304,924 | D |
| Open-market sales · 4,160 sh · avg $1.83 · $7,607 | |||||||
Loading xslF345X05/wk-form4_1769209883.xml…